Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial
Suzanne L Campion, Elena Brenna, Elaine Thomson, Will Fischer, Kristin Ladell, James E McLaren, David A Price, Nicole Frahm, Juliana M McElrath, Kristen W Cohen, Janine R Maenza, Stephen R Walsh, Lindsey R Baden, Barton F Haynes, Bette Korber, Persephone Borrow, Andrew J McMichael, Suzanne L Campion, Elena Brenna, Elaine Thomson, Will Fischer, Kristin Ladell, James E McLaren, David A Price, Nicole Frahm, Juliana M McElrath, Kristen W Cohen, Janine R Maenza, Stephen R Walsh, Lindsey R Baden, Barton F Haynes, Bette Korber, Persephone Borrow, Andrew J McMichael
Abstract
Naive and memory CD4+ T cells reactive with human immunodeficiency virus type 1 (HIV-1) are detectable in unexposed, unimmunized individuals. The contribution of preexisting CD4+ T cells to a primary immune response was investigated in 20 HIV-1-seronegative volunteers vaccinated with an HIV-1 envelope (Env) plasmid DNA prime and recombinant modified vaccinia virus Ankara (MVA) boost in the HVTN 106 vaccine trial (clinicaltrials.gov NCT02296541). Prevaccination naive or memory CD4+ T cell responses directed against peptide epitopes in Env were identified in 14 individuals. After priming with DNA, 40% (8/20) of the elicited responses matched epitopes detected in the corresponding preimmunization memory repertoires, and clonotypes were shared before and after vaccination in 2 representative volunteers. In contrast, there were no shared epitope specificities between the preimmunization memory compartment and responses detected after boosting with recombinant MVA expressing a heterologous Env. Preexisting memory CD4+ T cells therefore shape the early immune response to vaccination with a previously unencountered HIV-1 antigen.
Keywords: Cellular immune response; Clinical Trials; Immunology; T cells.
Figures
References
- Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today. 1998;19(9):395–404. doi: 10.1016/S0167-5699(98)01299-7.
- Chen W, et al. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity. 2000;12(1):83–93. doi: 10.1016/S1074-7613(00)80161-2.
- McHeyzer-Williams LJ, et al. Evolution of antigen-specific T cell receptors in vivo: preimmune and antigen-driven selection of preferred complementarity-determining region 3 (CDR3) motifs. J Exp Med. 1999;189(11):1823–1838. doi: 10.1084/jem.189.11.1823.
- McHeyzer-Williams MG, Davis MM. Antigen-specific development of primary and memory T cells in vivo. Science. 1995;268(5207):106–111. doi: 10.1126/science.7535476.
- Kaufmann DE, et al. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol. 2004;78(9):4463–4477. doi: 10.1128/JVI.78.9.4463-4477.2004.
- Kim A, Sadegh-Nasseri S. Determinants of immunodominance for CD4 T cells. Curr Opin Immunol. 2015;34:9–15. doi: 10.1016/j.coi.2014.12.005.
- Su LF, Davis MM. Antiviral memory phenotype T cells in unexposed adults. Immunol Rev. 2013;255(1):95–109. doi: 10.1111/imr.12095.
- Campion SL, et al. Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors. J Exp Med. 2014;211(7):1273–1280. doi: 10.1084/jem.20130555.
- Mateus J, et al. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020;370(6512):89–94. doi: 10.1126/science.abd3871.
- Su LF, et al. Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity. 2013;38(2):373–383. doi: 10.1016/j.immuni.2012.10.021.
- Mason D. Some quantitative aspects of T-cell repertoire selection: the requirement for regulatory T cells. Immunol Rev. 2001;182:80–88. doi: 10.1034/j.1600-065X.2001.1820106.x.
- Nikolich-Žugich J, et al. The many important facets of T-cell repertoire diversity. Nat Rev Immunol. 2004;4(2):123–132. doi: 10.1038/nri1292.
- Birnbaum ME, et al. Deconstructing the peptide-MHC specificity of T cell recognition. Cell. 2014;157(5):1073–1087. doi: 10.1016/j.cell.2014.03.047.
- Wooldridge L, et al. A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem. 2012;287(2):1168–1177. doi: 10.1074/jbc.M111.289488.
- Fazekas de St Groth, Webster RG. Disquisitions of Original Antigenic Sin. I. Evidence in man. J Exp Med. 1966;124(3):331–345. doi: 10.1084/jem.124.3.331.
- Santra S, et al. A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys. Proc Natl Acad Sci U S A. 2008;105(30):10489–10494. doi: 10.1073/pnas.0803352105.
- Gaschen B, et al. Diversity considerations in HIV-1 vaccine selection. Science. 2002;296(5577):2354–2360. doi: 10.1126/science.1070441.
- Goonetilleke N, et al. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes. J Virol. 2006;80(10):4717–4728. doi: 10.1128/JVI.80.10.4717-4728.2006.
- Hladik F, et al. Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells. J Immunol. 2003;171(5):2671–2683. doi: 10.4049/jimmunol.171.5.2671.
- Ritchie AJ, et al. Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals. J Virol. 2011;85(7):3507–3516. doi: 10.1128/JVI.02444-10.
- Geiger R, et al. Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med. 2009;206(7):1525–1534. doi: 10.1084/jem.20090504.
- Boyer JD, et al. Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines. J Infect Dis. 2000;181(2000):476–483.
- MacGregor RR, et al. T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev. AIDS. 2002;16(16):2137–2143. doi: 10.1097/00002030-200211080-00005.
- Mwau M, et al. A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. J Gen Virol. 2004;85(pt 4):911–919.
- Ogbe A, et al. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nat Commun. 2021;12(1):2055. doi: 10.1038/s41467-021-21856-3.
- Elias G, et al. Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon vaccination [preprint]. Posted on bioRxiv March 03, 2021.
Source: PubMed